Since November 2018 clinicians can prescribe cannabis-based products for medicinal use (CBPMs), but NHS prescriptions are tightly managed and relatively rare. Usual conditions wherever CBPMs could be considered consist of serious, remedy-resistant epilepsy plus some suffering/spasticity conditions — and perhaps then it always needs a specialist healthcare facility guide to https://helpmehigh.com/